** BMO initiates coverage on the real estate investment trust Alexandria Real Estate Equities ARE.N with "outperform" rating; PT at $100
** New PT represents an upside of 16.4% from the stock's last close
** Brokerage says ARE's core business is facing pressure from oversupply and weak demand, but its strong portfolio and discounted valuation could benefit from a rebound in the biopharma sector
** BMO views co as a resilient and well-positioned leader in life sciences, offering attractive potential for steady returns and growth
** Brokerage expects 2025 funds from operations (FFO) of $8.33
** Six of 14 brokerages rate the stock "buy" or higher, eight "hold"; their median PT is $91- data compiled by LSEG
** As of last close, stock had fallen 12% YTD